2013 Statements and Testimony

April 17, 2013 - ASM Sends Letter to Congress Regarding FY 2014 Funding
The ASM signed onto a letter as a member of the Informal Coalition on Biodefense and Public Health Preparedness to support funding for programs critical to the nation’s preparedness against threats, whether naturally occurring or deliberate, such as a chemical, biological, radiological, and nuclear (CBRN) event.

April 17, 2013 - ASM Signs onto Coalition CLFS Letter
The ASM signed onto a letter from the Clinical Laboratory Coalition outlining serious concern and opposition to further reducing the Medicare Part B Clinical Laboratory Fee Schedule (CLFS) as proposed in the President’s 2014 Budget.  It was sent to the Chair and Ranking Member of the Senate Finance Committee.

March 27, 2013 - ASM Comments on Dual Use Research Policy
ASM sent comments to the Office of Science and Technology Policy regarding the February 22, 2013 United States Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern.

March 25, 2013 - ASM Comments on NIH Recombinant DNA Molecules Guidelines
The ASM sent comments to the NIH's Office of Biotechnology Activities regarding changes to the NIH Guidelines for Research Involving Recombinant DNA Molecules.

March 22, 2013 - ASM Appropriation Statements for FY 2014
The ASM has submitted appropriation recommendations for federal agencies that support biomedical and public health research.

• National Institutes of Health
• Centers for Disease Control and Prevention
• U.S. Department of Agriculture
• Food and Drug Administration
• National Science Foundation
• Department of Energy

March 19, 2013 - ASM Signs onto Coalition Letter Concerning AFRI
The ASM joined with the Agriculture and Food Research Initiative (AFRI) Coalition to send a letter to Congress regarding funding for AFRI. 

February 11, 2013 - ASM Signs onto Coalition Letter Concerning the Impact of Continued Cuts to the NIH Budget
The ASM signed onto an Ad Hoc Group for Medical Research-led community sign-on letter expressing concern about the impact of continued cuts to NIH. The letter was sent to all Members of Congress, with a total of 273 signatories.

January 7, 2013 - ASM Comments on Proposed Framework for Guiding HHS Funding Decisions about Highly Pathogenic Avian Influenza H5N1 Gain-of-Function Research
The ASM submitted comments to the National Institutes of Health on the Proposed Framework for Guiding HHS Funding Decisions about Highly Pathogenic Avian Influenza H5N1 Gain-of-Function Research.